Population and evolutionary genetics of the PAH locus to uncover overdominance and adaptive mechanisms in phenylketonuria: Results from a multiethnic study.
Biological Evolution
Ethnicity
/ genetics
Exome
/ genetics
Female
France
Gene Frequency
/ genetics
Genetic Association Studies
Genetic Loci
Genetics, Population
Geography
Haplotypes
/ genetics
Humans
Male
Phenylalanine Hydroxylase
/ genetics
Phenylketonurias
/ genetics
Phylogeny
Principal Component Analysis
Balancing selection
Metabolic adaptation
Overdominance
Phenylketonuria
Population divergence
Journal
EBioMedicine
ISSN: 2352-3964
Titre abrégé: EBioMedicine
Pays: Netherlands
ID NLM: 101647039
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
30
11
2019
revised:
20
12
2019
accepted:
22
12
2019
pubmed:
11
1
2020
medline:
2
10
2020
entrez:
11
1
2020
Statut:
ppublish
Résumé
Phenylketonuria (PKU) is the most common inborn error of amino acid metabolism in Europe. The reasons underlying the high prevalence of heterozygous carriers are not clearly understood. We aimed to look for pathogenic PAH variant enrichment according to geographical areas and patients' ethnicity using a multiethnic nationwide cohort of patients with PKU in France. We subsequently appraised the population differentiation, balancing selection and the molecular evolutionary history of the PAH locus. The French nationwide PKU study included patients who have been referred at the national level to the University Hospital of Nancy, and for whom a molecular diagnosis of phenylketonuria was made by Sanger sequencing. We performed enrichment analyses by comparing alternative allele frequencies using Fisher's exact test with Bonferroni adjustment. We estimated the amount of genetic differentiation among populations using Wright's fixation index (Fst). To estimate the molecular evolutionary history of the PAH gene, we performed phylogenetic and evolutionary analyses using whole-genome and exome-sequencing data from healthy individuals and non-PKU patients, respectively. Finally, we used exome-wide association study to decipher potential genetic loci associated with population divergence on PAH. The study included 696 patients and revealed 132 pathogenic PAH variants. Three geographical areas showed significant enrichment for a pathogenic PAH variant: North of France (p.Arg243Leu), North-West of France (p.Leu348Val), and Mediterranean coast (p.Ala403Val). One PAH variant (p.Glu280Gln) was significantly enriched among North-Africans (OR = 23·23; 95% CI: 9·75-55·38). PAH variants exhibiting a strong genetic differentiation were significantly enriched in the 'Biopterin_H' domain (OR = 6·45; 95% CI: 1·99-20·84), suggesting a balancing selection pressure on the biopterin function of PAH. Phylogenetic and timetree analyses were consistent with population differentiation events on European-, African-, and Asian-ancestry populations. The five PAH variants most strongly associated with a high selection pressure were phylogenetically close and were located within the biopterin domain coding region of PAH or in its vicinity. Among the non-PAH loci potentially associated with population divergence, two reached exome-wide significance: SSPO (SCO-spondin) and DBH (dopamine beta-hydroxylase), involved in neuroprotection and metabolic adaptation, respectively. Our data provide evidence on the combination of evolutionary and adaptive events in populations with distinct ancestries, which may explain the overdominance of some genetic variants on PAH. French National Institute of Health and Medical Research (INSERM) UMR_S 1256.
Sections du résumé
BACKGROUND
BACKGROUND
Phenylketonuria (PKU) is the most common inborn error of amino acid metabolism in Europe. The reasons underlying the high prevalence of heterozygous carriers are not clearly understood. We aimed to look for pathogenic PAH variant enrichment according to geographical areas and patients' ethnicity using a multiethnic nationwide cohort of patients with PKU in France. We subsequently appraised the population differentiation, balancing selection and the molecular evolutionary history of the PAH locus.
METHODS
METHODS
The French nationwide PKU study included patients who have been referred at the national level to the University Hospital of Nancy, and for whom a molecular diagnosis of phenylketonuria was made by Sanger sequencing. We performed enrichment analyses by comparing alternative allele frequencies using Fisher's exact test with Bonferroni adjustment. We estimated the amount of genetic differentiation among populations using Wright's fixation index (Fst). To estimate the molecular evolutionary history of the PAH gene, we performed phylogenetic and evolutionary analyses using whole-genome and exome-sequencing data from healthy individuals and non-PKU patients, respectively. Finally, we used exome-wide association study to decipher potential genetic loci associated with population divergence on PAH.
FINDINGS
RESULTS
The study included 696 patients and revealed 132 pathogenic PAH variants. Three geographical areas showed significant enrichment for a pathogenic PAH variant: North of France (p.Arg243Leu), North-West of France (p.Leu348Val), and Mediterranean coast (p.Ala403Val). One PAH variant (p.Glu280Gln) was significantly enriched among North-Africans (OR = 23·23; 95% CI: 9·75-55·38). PAH variants exhibiting a strong genetic differentiation were significantly enriched in the 'Biopterin_H' domain (OR = 6·45; 95% CI: 1·99-20·84), suggesting a balancing selection pressure on the biopterin function of PAH. Phylogenetic and timetree analyses were consistent with population differentiation events on European-, African-, and Asian-ancestry populations. The five PAH variants most strongly associated with a high selection pressure were phylogenetically close and were located within the biopterin domain coding region of PAH or in its vicinity. Among the non-PAH loci potentially associated with population divergence, two reached exome-wide significance: SSPO (SCO-spondin) and DBH (dopamine beta-hydroxylase), involved in neuroprotection and metabolic adaptation, respectively.
INTERPRETATION
CONCLUSIONS
Our data provide evidence on the combination of evolutionary and adaptive events in populations with distinct ancestries, which may explain the overdominance of some genetic variants on PAH.
FUNDING
BACKGROUND
French National Institute of Health and Medical Research (INSERM) UMR_S 1256.
Identifiants
pubmed: 31923802
pii: S2352-3964(19)30838-2
doi: 10.1016/j.ebiom.2019.102623
pmc: PMC7000351
pii:
doi:
Substances chimiques
Phenylalanine Hydroxylase
EC 1.14.16.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
102623Informations de copyright
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors who have taken part in this study declare that they do not have anything to disclose regarding conflicts of interest concerning this manuscript.
Références
Ir Med J. 1976 Sep 30;69(15):405-10
pubmed: 1010731
Genes Dis. 2015 Feb 25;2(3):247-254
pubmed: 30258868
J Med Genet. 1978 Jun;15(3):246-8
pubmed: 671494
Free Radic Biol Med. 2012 Apr 1;52(7):1123-34
pubmed: 22300645
Methods Mol Biol. 2010;628:341-72
pubmed: 20238091
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11479-84
pubmed: 11562485
Hum Mutat. 2007 Sep;28(9):831-45
pubmed: 17443661
Front Physiol. 2019 Aug 28;10:1116
pubmed: 31555147
J Med Genet. 1977 Feb;14(1):20-4
pubmed: 839495
Nucleic Acids Res. 2019 Jul 2;47(W1):W623-W631
pubmed: 31045209
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
Am J Hum Genet. 2017 Nov 2;101(5):752-767
pubmed: 29100088
Am J Hum Genet. 1996 Jul;59(1):84-94
pubmed: 8659548
Mol Genet Metab. 2010;99 Suppl 1:S100-5
pubmed: 20123463
Eur J Hum Genet. 2015 Jun;23(6):831-6
pubmed: 25182131
Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):7485-90
pubmed: 27325755
Proc Natl Acad Sci U S A. 2007 May 15;104 Suppl 1:8655-60
pubmed: 17494744
JIMD Rep. 2018;42:71-77
pubmed: 29288420
PLoS One. 2018 Dec 6;13(12):e0207677
pubmed: 30521541
Nat Rev Genet. 2017 Oct;18(10):599-612
pubmed: 28804138
Orphanet J Rare Dis. 2015 Dec 15;10:158
pubmed: 26666653
J Inherit Metab Dis. 1986;9 Suppl 2:169-77
pubmed: 2877115
JIMD Rep. 2014;13:101-9
pubmed: 24190797
Genetics. 1964 Jan;49(1):49-67
pubmed: 17248194
Science. 2014 Feb 14;343(6172):747-751
pubmed: 24531965
PLoS Pathog. 2015 Mar 12;11(3):e1004667
pubmed: 25764397
Science. 2002 Jun 21;296(5576):2225-9
pubmed: 12029063
J Med Genet. 1978 Aug;15(4):317-9
pubmed: 568666
BMC Med. 2015 Jun 12;13:140
pubmed: 26071312
J Inherit Metab Dis. 2018 Nov;41(6):1159-1167
pubmed: 30159852
Nat Genet. 2013 Feb;45(2):197-201
pubmed: 23263489
PLoS One. 2014 Mar 25;9(3):e93179
pubmed: 24667843
Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):19333-8
pubmed: 23129628
PLoS Biol. 2012;10(9):e1001388
pubmed: 22984349
Nat Commun. 2018 Jan 4;9(1):67
pubmed: 29302025
Nat Rev Genet. 2014 Jun;15(6):379-93
pubmed: 24776769
Genet Med. 2016 Oct;18(10):1029-36
pubmed: 26890452
Nature. 2017 Jan 18;541(7637):302-310
pubmed: 28102248
Sci Rep. 2018 Jul 26;8(1):11251
pubmed: 30050108
FEBS Lett. 2004 Nov 19;577(3):507-11
pubmed: 15556637
JIMD Rep. 2017;34:19-26
pubmed: 27469133
Am J Hum Genet. 1998 Jul;63(1):71-9
pubmed: 9634518
Curr Protoc Hum Genet. 2017 Oct 18;95:1.22.1-1.22.23
pubmed: 29044472
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Am J Hum Genet. 1986 May;38(5):773-5
pubmed: 3717163
ACS Infect Dis. 2016 Nov 11;2(11):827-838
pubmed: 27641435
Hum Mutat. 2003 Apr;21(4):394-7
pubmed: 12655549
Am J Hum Genet. 2008 Jul;83(1):132-5; author reply 135-9
pubmed: 18606306
Ann Eugen. 1951 Mar;15(4):323-54
pubmed: 24540312
Orphanet J Rare Dis. 2017 Oct 12;12(1):162
pubmed: 29025426
J Neurochem. 2003 Aug;86(3):615-26
pubmed: 12859675
Mol Biol Evol. 1993 May;10(3):512-26
pubmed: 8336541
BMC Med Genet. 2017 Oct 5;18(1):108
pubmed: 28982351
Ann Hum Genet. 1975 May;38(4):461-9
pubmed: 1190737
Evolution. 1984 Nov;38(6):1358-1370
pubmed: 28563791
Am J Hum Genet. 1994 Aug;55(2):321-6
pubmed: 7913581
PLoS Genet. 2006 Apr;2(4):e64
pubmed: 16683038
Nature. 1967 Mar 4;213(5079):882-3
pubmed: 6030045
Theor Popul Biol. 2011 Feb-Mar;79(1-2):39-52
pubmed: 21094655
PLoS Genet. 2014 Aug 21;10(8):e1004561
pubmed: 25144706